(Q43454000)

23 November 2017

0 references

Immunologic tolerability profile of celecoxib (English)

1 reference

23 November 2017

Patterson R

1

1 reference

PubMed ID

10645754

23 November 2017

Bello AE

series ordinal

2

1 reference

PubMed ID

10645754

23 November 2017

Lefkowith J

series ordinal

3

1 reference

23 November 2017

1 December 1999

1 reference

23 November 2017

Clinical Therapeutics

1 reference

23 November 2017

21

1 reference

23 November 2017

2065-2079

1 reference

23 November 2017

12

1 reference

Drugs as allergens: detection and combining site specificities of IgE antibodies to sulfamethoxazole

23 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2987238-0

7 January 2021

Immunochemical analysis of sulfonamide drug allergy: identification of sulfamethoxazole-substituted human serum proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2987238-0

7 January 2021

Cross-reactions among furosemide, hydrochlorothiazide, and sulfonamides

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2987238-0

7 January 2021

Studies of human IgE to a sulfonamide determinant

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2987238-0

7 January 2021

Detection of human IgE to sulfamethoxazole by skin testing with sulfamethoxazoyl-poly-L-tyrosine

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2987238-0

7 January 2021

Glutathione in hypersensitivity to trimethoprim/sulfamethoxazole in patients with HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2987238-0

7 January 2021

Severe adverse cutaneous reactions to drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2987238-0

7 January 2021

Differences in metabolism of sulfonamides predisposing to idiosyncratic toxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2987238-0

7 January 2021

Synthesis and biological evaluation of the 1,5-diarylpyrazole class of cyclooxygenase-2 inhibitors: identification of 4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benze nesulfonamide (SC-58635, celecoxib).

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2987238-0

7 January 2021

Preliminary study of the safety and efficacy of SC-58635, a novel cyclooxygenase 2 inhibitor: efficacy and safety in two placebo-controlled trials in osteoarthritis and rheumatoid arthritis, and studies of gastrointestinal and platelet effects

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2987238-0

7 January 2021

Toxicity of nonsteroidal anti-inflammatory drugs. An overview of the epidemiological evidence.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2987238-0

7 January 2021

Anaphylaxis to intravenous furosemide

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2987238-0

7 January 2021

10.1016/S0149-2918(00)87238-0

Identifiers

DOI

1 reference

23 November 2017

1 reference

PubMed ID

10645754